BackZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) Overview
ZyVersa Therapeutics Inc - Units (1 Ord Share Class A & 3/4 War)

ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) P/E Ratio

Latest P/E ratio for ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War): -0.03 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

-0.03

P/E Ratio

-0.03

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) (LSPRU) FAQ

ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) (LSPRU) currently reports a P/E ratio of -0.03. That is below the sector sector average of 34.88. Use the charts on this page to explore ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)'s P/E ratio history and peer comparisons.

ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)'s P/E ratio of -0.03 is lower than the its sector sector average of 34.88. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)'s market price to a fundamental measure such as earnings, sales, or book value. At -0.03, LSPRU can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -0.03, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 34.88. From there, open related valuation or income-statement pages for ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War), and consider following LSPRU for alerts when major investors trade the stock.